Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00450112 · ClinicalTrials.gov registry record · Phase 3
Gel-200 Extension and Open-Label Study in Osteoarthritis of the Knee
A Phase 3 study, sponsored by Seikagaku Corporation.
- Completed
- Registry status
- Phase 3
- Development phase
- 202
- Enrollment target
NCT00450112: Completed Phase 3 study, sponsored by Seikagaku Corporation.
NCT00450112 is a Phase 3 study that has completed, run by Seikagaku Corporation. The registered enrollment target is 202 participants, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (74% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00450112, a Phase 3 study, has completed, sponsored by Seikagaku Corporation.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 202 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if a single or repeat intra-articular injection of Gel-200 is safe and effective in subjects with symptomatic osteoarthritis of the knee and to determine if original SI-6606/01 Gel-200 therapy is durable beyond the original study.
Interventions
- DEVICE Gel-200
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 202 participants |
| Start Date | 2007-03 |
| Est. Completion | 2009-06 |
| Phase | Phase 3 |
What the finished NCT00450112 record still lists
NCT00450112 is an interventional study that assigns participants to a tested intervention. The registered 202 participants enrollment target is mid-sized for trials with a published cap, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (74% lower).
The record links to 0 conditions, and to 1 intervention - of which Gel-200 is the first listed.
NCT00450112 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00450112 about?
NCT00450112 is a clinical study titled "Gel-200 Extension and Open-Label Study in Osteoarthritis of the Knee". The purpose of this study is to determine if a single or repeat intra-articular injection of Gel-200 is safe and effective in subjects with symptomatic osteoarthritis of the knee and to determine if original SI-6606/01 Gel-200 therapy is durable beyond the original study.
What is the current status of trial NCT00450112?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 202 participants. The study started on 2007-03. Estimated completion is 2009-06.
What interventions are being tested in trial NCT00450112?
The interventions under investigation include: Gel-200 (DEVICE).
Who is sponsoring clinical trial NCT00450112?
This trial is sponsored by Seikagaku Corporation, which has 12 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00450112's enrollment target sits among peer trials
202 1353rd of 2000 higher than 648 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05272254 · 202 participants · Phase 2
Povidone Iodine Efficacy Study
- NCT05701280 · 202 participants · NA
Pilot/Pivotal Study of DBS+Rehab After Stroke
- NCT05932589 · 202 participants
Neurophysiologic Biomarkers in Rett Syndrome
- NCT06014931 · 202 participants · NA
Telehealth-enhanced Patient-oriented Recovery Trajectory After Intensive Care
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia